These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 1706198)

  • 21. Role of G-CSF GM-CSF in the management of infections in preterm newborns: an update.
    Castagnola E; Dufour C
    Early Hum Dev; 2014 Sep; 90 Suppl 2():S15-7. PubMed ID: 25220119
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Report on the current indications for colony stimulating factors (G-CSF and GM-CSF)].
    Med Clin (Barc); 1994 May; 102(19):747-50. PubMed ID: 7518884
    [No Abstract]   [Full Text] [Related]  

  • 23. Granulocyte colony stimulating factor in the management of chronic neutropenia.
    Marlton PV; Wright SJ; Taylor KM
    Med J Aust; 1992 May; 156(10):729-31. PubMed ID: 1377771
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of malignant lymphoma.
    Bohlius J; Reiser M; Schwarzer G; Engert A
    Cochrane Database Syst Rev; 2004; (3):CD003189. PubMed ID: 15266474
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Myeloid growth factors can cure chronic neutropenia and facilitate cytostatic therapy].
    Palmblad J; Samuelsson J
    Lakartidningen; 1992 Mar; 89(13):1037-8, 1041. PubMed ID: 1372671
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparative effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor after high-dose cyclophosphamide cancer therapy.
    Bregni M; Siena S; Di Nicola M; Dodero A; Peccatori F; Ravagnani F; Danesini G; Laffranchi A; Bonadonna G; Gianni AM
    J Clin Oncol; 1996 Feb; 14(2):628-35. PubMed ID: 8636780
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (2).
    Lieschke GJ; Burgess AW
    N Engl J Med; 1992 Jul; 327(2):99-106. PubMed ID: 1376442
    [No Abstract]   [Full Text] [Related]  

  • 28. [G-CSF and GM-CSF in neutropenia of various origins].
    Kuliczkowski K
    Pol Arch Med Wewn; 2001; 105 Suppl():133-4. PubMed ID: 12412234
    [No Abstract]   [Full Text] [Related]  

  • 29. [Myeloid hemopoietic growth factors. Therapeutic possibilities and clinical experiences].
    Hansen B; Johnsen HE
    Ugeskr Laeger; 1990 Oct; 152(44):3232-7. PubMed ID: 1700524
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glycogen storage disease type Ib: infectious complications and measures for prevention.
    Wendel U; Schroten H; Burdach S; Wahn V
    Eur J Pediatr; 1993; 152 Suppl 1():S49-51. PubMed ID: 7686491
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Granulocyte and macrophage colony stimulating factor (GM-CSF) in patients with acquired immunodeficiency syndrome and neutropenia].
    Martos A; Domínguez MA; Martínez Lacasa J; Podzamczer D
    Med Clin (Barc); 1992 Jun; 99(5):196-7. PubMed ID: 1507903
    [No Abstract]   [Full Text] [Related]  

  • 32. [The dilemma of stimulating factors in the recovery from chemotherapeutic neutropenia].
    Borbollo Escoboza JR; González Avante M; Alvarado Ibarra M
    Rev Invest Clin; 1996; 48(4):328. PubMed ID: 8966397
    [No Abstract]   [Full Text] [Related]  

  • 33. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor: comparisons and potential for use in the treatment of infections in nonneutropenic patients.
    Root RK; Dale DC
    J Infect Dis; 1999 Mar; 179 Suppl 2():S342-52. PubMed ID: 10081506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The promise of colony-stimulating factors in clinical practice.
    Glaspy JA; Ambersley JM
    Oncol Nurs Forum; 1990; 17(1 Suppl):20-4. PubMed ID: 1689043
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Granulocyte-macrophage colony-stimulating factor or granulocyte colony-stimulating factor infusion makes high-dose etoposide a safe outpatient regimen that is effective in lymphoma and myeloma patients.
    Gianni AM; Bregni M; Siena S; Magni M; Di Nicola M; Lombardi F; Tarella C; Pileri A; Bonadonna G
    J Clin Oncol; 1992 Dec; 10(12):1955-62. PubMed ID: 1280674
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhancement of in vitro and in vivo anti-tumor activity of anti-GD2 monoclonal antibody 220-51 against human neuroblastoma by granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor.
    Fukuda M; Horibe K; Furukawa K
    Int J Mol Med; 1998 Oct; 2(4):471-5. PubMed ID: 9857237
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The granulocyte/macrophage-colony stimulating factor (GM-CSF): basic science and clinical application.
    Burdach S
    Klin Padiatr; 1991; 203(4):302-10. PubMed ID: 1942937
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Granulocyte colony-stimulating factors.
    Med Lett Drugs Ther; 1991 Jun; 33(847):61-3. PubMed ID: 1710761
    [No Abstract]   [Full Text] [Related]  

  • 39. Increased levels of multiple forms of dihydrofolate reductase in peripheral blood leucocytes of cancer patients receiving haematopoietic colony-stimulating factors: interim analysis.
    Iqbal MP; Burney IA; Sultana F; Mehboobali N; Siddiqui T
    Exp Mol Med; 2000 Jun; 32(2):84-7. PubMed ID: 10926120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. G- and GM-CSF.
    Middleton M; Thatcher N
    Int J Antimicrob Agents; 1998 May; 10(2):91-3. PubMed ID: 9716285
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.